Fetal Anomalies Scan at the Time of Nuchal Translucency Study

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00943189

Enrollment

600

Registered

2009-07-22

Start date

2008-06-30

Completion date

Unknown

Last updated

2009-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fetal Anomalies

Keywords

Fetal anomalies scan at the time of NT study

Brief summary

Purpose: Fetal anomalies scan at the time of Nuchal Translucency (NT) study.

Detailed description

Prospective study of patients at 12-14 weeks gestation that are coming for NT examination is conducted. Meticulous ultrasound examination will be done to the fetuses using trans vaginal and transabdominal techniques. The patients will receive only the NT information. Only in cases of detection of severe fetal anomalies the patient will get the information of the examination and counseling according to the findings. All patients will be asked to provide information of the 15 weeks early comprehensive ultrasound examination. The NT examination will be compared to the 15 weeks ultrasound. All patients will be asked to give information after delivery of the baby's health condition.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Healthy volunteers

Yes

Inclusion criteria

* pregnant women at 12-14 weeks

Exclusion criteria

Countries

Israel

Contacts

Primary ContactLiat Gindes, MD

gindesl@smile.net.il

Outcome results